HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hinrich Abken Selected Research

B-Cell Leukemia (Leukemia, B Cell)

10/2022Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials.
1/2018Nanobody Based Dual Specific CARs.
1/2018CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple Myeloma.
1/2018CAR T Cells in Trials: Recent Achievements and Challenges that Remain in the Production of Modified T Cells for Clinical Applications.
8/2015Chimeric antigen receptor T cells: power tools to wipe out leukemia and lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hinrich Abken Research Topics

Disease

82Neoplasms (Cancer)
10/2022 - 05/2002
17Lymphoma (Lymphomas)
10/2022 - 06/2004
12Leukemia
10/2022 - 01/2013
10Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2014
7Hodgkin Disease (Hodgkin's Disease)
12/2020 - 09/2003
6Melanoma (Melanoma, Malignant)
12/2015 - 03/2010
5B-Cell Leukemia (Leukemia, B Cell)
10/2022 - 08/2015
4Carcinoma (Carcinomatosis)
09/2020 - 11/2008
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 10/2012
3Adenocarcinoma
03/2022 - 10/2012
3Inflammation (Inflammations)
01/2017 - 01/2003
3Infections
11/2015 - 04/2010
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2021 - 01/2018
2Breast Neoplasms (Breast Cancer)
02/2020 - 01/2020
2Colonic Neoplasms (Colon Cancer)
10/2019 - 01/2015
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 01/2016
2Chronic Hepatitis B
08/2013 - 01/2008
1Prostatic Neoplasms (Prostate Cancer)
09/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2018
1Multiple Myeloma
01/2018
1Asthma (Bronchial Asthma)
01/2017
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2017
1Hepatitis
11/2015
1Meningitis
11/2015
1Hypersensitivity (Allergy)
11/2015
1Immune System Diseases (Immune Disorders)
01/2015
1Stomach Neoplasms (Stomach Cancer)
01/2015
1Virus Diseases (Viral Diseases)
01/2015
1Rhabdomyosarcoma
06/2013
1Basal Cell Carcinoma (Rodent Ulcer)
01/2013
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2013
1Osteoarthritis
11/2012
1Neoplasm Metastasis (Metastasis)
11/2012

Drug/Important Bio-Agent (IBA)

51Chimeric Antigen ReceptorsIBA
10/2022 - 10/2007
36AntigensIBA
10/2022 - 05/2002
22CytokinesIBA
01/2022 - 09/2003
13Interleukin-12 (IL 12)IBA
01/2022 - 01/2003
8Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2003
6Carcinoembryonic AntigenIBA
10/2019 - 03/2007
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2017 - 05/2002
5Monoclonal AntibodiesIBA
01/2020 - 05/2002
4Neoplasm Antigens (Tumor Antigens)IBA
01/2021 - 09/2011
3AntibodiesIBA
01/2020 - 01/2003
3HMW-MAAIBA
12/2015 - 03/2010
3Interleukin-2 (IL2)IBA
01/2012 - 06/2005
2EpitopesIBA
09/2020 - 01/2020
2Interleukin-18 (Interleukin 18)IBA
02/2020 - 12/2017
2InterleukinsIBA
02/2020 - 03/2013
2Trastuzumab (Herceptin)FDA Link
02/2020 - 01/2020
2Pharmaceutical PreparationsIBA
01/2020 - 02/2011
2Granzymes (Granzyme)IBA
08/2016 - 03/2014
2Interleukin-10 (Interleukin 10)IBA
11/2015 - 03/2007
2Messenger RNA (mRNA)IBA
10/2014 - 01/2012
2Antiviral Agents (Antivirals)IBA
08/2013 - 01/2008
2Immunoglobulin FragmentsIBA
01/2003 - 05/2002
1CannabinoidsIBA
03/2022
1CannabidiolIBA
03/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2022
1tisagenlecleucelIBA
04/2021
1axicabtagene ciloleucelIBA
04/2021
1Mitochondrial DNA (mtDNA)IBA
12/2020
1Docetaxel (Taxotere)FDA Link
09/2020
1Interleukin-7 (Interleukin 7)IBA
01/2020
1Immunotoxins (Immunotoxin)IBA
10/2019
1ErbB Receptors (EGF Receptor)IBA
10/2019
1LigandsIBA
10/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2018
1B-Cell Maturation AntigenIBA
01/2018
1Folic Acid (Vitamin M)FDA LinkGeneric
02/2017
1AllergensIBA
01/2017
1Cell Surface ReceptorsIBA
01/2017
1Serine Proteases (Serine Protease)IBA
08/2016
1CatalaseIBA
01/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016
1Transfer RNA (tRNA)IBA
12/2015
1RNA (Ribonucleic Acid)IBA
12/2015
1CD19 AntigensIBA
10/2015
1WT1 ProteinsIBA
08/2015
1Epithelial Cell Adhesion MoleculeIBA
01/2015
1Differentiation AntigensIBA
01/2015
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2015
1Death Domain ReceptorsIBA
03/2014
1Inhibitor of Apoptosis ProteinsIBA
03/2014
1CaspasesIBA
03/2014
1PerforinIBA
03/2014
1Cholinergic ReceptorsIBA
06/2013
1SurvivinIBA
06/2013
1Annexin A6IBA
11/2012
1CollagenIBA
11/2012
1Annexin A5IBA
11/2012

Therapy/Procedure

40Therapeutics
10/2022 - 01/2008
21Immunotherapy
09/2020 - 04/2003
15Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021 - 06/2010
3Injections
09/2020 - 01/2012
2Drug Therapy (Chemotherapy)
09/2020 - 01/2012
1Blood Component Removal (Apheresis)
01/2022
1Combination Drug Therapy (Combination Chemotherapy)
06/2013
1Intravenous Injections
11/2012